Poland - Pharmaceutical products - Supply of a medicinal product containing the active substance BELANTAMAB MAFODOTIN - no. 66/PN/2026

different companies won its awards

120

of the awards went to the three most frequent winners

7%

of its calls state an estimated value

100%

Based on 134 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)

1.9

of those lots received a single tender

65%

of the awards went to companies based in another country

2%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

Poland · Medical equipment & pharmaceuticals

different companies won awards here

13,478

of the awards went to the three most frequent winners

4%

buyers awarded contracts here

1,464

Based on 23,086 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)

1.8

of those lots received a single tender

63%

of the awards went to companies based in another country

2%

of the tenders came from another country

2%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.